1Department of Neurologic Surgery and.
2Neuro-Informatics Laboratory, Mayo Clinic, Rochester, Minnesota.
Neurosurg Focus. 2022 Jun;52(6):E10. doi: 10.3171/2022.3.FOCUS2243.
The coronavirus disease 2019 (COVID-19) pandemic has significantly changed clinical practice across US healthcare. Increased adoption of telemedicine has emerged as an alternative to in-person contact for patient-physician interactions. The aim of this study was to analyze the impact of telemedicine on workflow and care delivery from January 2019 to December 2021 in a neurosurgical department at a quaternary care center.
Prospectively captured data on clinic appointment utilization, duration, and outcomes were queried. Visits were divided into in-person visits and telemedicine appointments, categorized as follow-up visits of previously surgically treated patients, internal consultations, new patient visits, and early postoperative returns after surgery. Appointment volume was compared pre- and postpandemic using March 2020 as the pandemic onset. Clinical efficiency was measured by time to appointment, rate of on-time appointments, proportion of appointments resulting in surgical intervention (surgical yield), and patient-reported satisfaction, the latter measured as the proportion of patients indicating "high likelihood to recommend practice."
A total of 54,562 visits occurred, most commonly for follow-up for previously operated patients (51.8%), internal new patient referrals (24.5%), and external new patient referrals (19.8%). Total visit volume was stable pre- to postpandemic (1521.3 vs 1512, p = 0.917). However, in-person visits significantly decreased (1517/month vs 1220/month, p < 0.001), with a nadir in April 2020, while telemedicine appointment utilization increased significantly (0.3% vs 19.1% of all visits). Telemedicine utilization remained stable throughout the 1st calendar year following the pandemic. Telemedicine appointments were associated with shorter time to appointment than in-person visits both before and after the pandemic onset (0-5 days from appointment request: 60% vs 33% vs 29.8%, p < 0.001). Patients had on-time appointments in 87% of telemedicine encounters. Notably, telemedicine appointments resulted in surgery in 31.8% of internal consultations or new patient visits, a significantly lower rate than that for in-person visits (51.8%). After the widespread integration of telemedicine, patient satisfaction for all visits was higher than before the pandemic onset (85.9% vs 88.5%, p = 0.027).
Telemedicine use significantly increased following the pandemic onset, compensating for observed decreases in face-to-face visits. Utilization rates have remained stable, suggesting effective integration, and delays between referrals and appointments were lower than for in-person visits. Importantly, telemedicine integration was not associated with a decrease in overall patient satisfaction, although telemedicine appointments had a lower surgical yield. These data suggest that telemedicine smoothened the impact of the pandemic on clinical workflow and helped to maintain continuity and quality of outpatient care.
2019 年冠状病毒病(COVID-19)大流行极大地改变了美国医疗保健领域的临床实践。远程医疗的广泛采用已成为医患互动的一种替代方式,以代替面对面的接触。本研究旨在分析 2019 年 1 月至 2021 年 12 月在一家四级保健中心的神经外科部门采用远程医疗对工作流程和医疗服务的影响。
前瞻性地查询了门诊预约利用、持续时间和结果数据。就诊分为面对面就诊和远程医疗预约,分为先前手术治疗患者的随访就诊、内部咨询、新患者就诊和手术后早期返回。使用 2020 年 3 月作为大流行开始,比较大流行前后的预约量。临床效率通过预约时间、按时预约率、导致手术干预的预约比例(手术产量)以及患者报告的满意度来衡量,后者通过表示“高度可能推荐实践”的患者比例来衡量。
共进行了 54562 次就诊,最常见的是先前手术治疗患者的随访就诊(51.8%)、内部新患者转诊(24.5%)和外部新患者转诊(19.8%)。大流行前和大流行后的总就诊量保持稳定(1521.3 次/月与 1512 次/月,p=0.917)。然而,面对面就诊显著减少(1517 次/月与 1220 次/月,p<0.001),2020 年 4 月达到最低点,而远程医疗预约利用率显著增加(从预约请求到预约的 0-5 天:60%与 33%与 29.8%,p<0.001)。远程医疗预约在大流行开始前后都比面对面就诊预约时间更短(0-5 天:60%与 33%与 29.8%,p<0.001)。远程医疗就诊中,87%的患者按时就诊。值得注意的是,内部咨询或新患者就诊的远程医疗预约中,有 31.8%的患者进行了手术,这一比例明显低于面对面就诊(51.8%)。在远程医疗广泛整合后,所有就诊的患者满意度均高于大流行前(85.9%与 88.5%,p=0.027)。
大流行开始后,远程医疗的使用显著增加,弥补了面对面就诊的减少。利用率保持稳定,表明有效整合,转诊和预约之间的延迟低于面对面就诊。重要的是,远程医疗的整合并没有降低患者的整体满意度,尽管远程医疗预约的手术产量较低。这些数据表明,远程医疗缓解了大流行对临床工作流程的影响,并有助于维持门诊医疗服务的连续性和质量。